Teva Pharmaceutical Industries (NYSE:TEVA) Upgraded by Argus to “Buy”
Argus upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from a hold rating to a buy rating in a research report report published on Wednesday, MarketBeat.com reports. Argus currently has $20.00 price target on the stock. A number of other brokerages have also recently weighed in on TEVA. Bank of America lifted their […]
More Stories
John Hancock Preferred Income Fund (NYSE:HPI) Short Interest Down 31.3% in November
John Hancock Preferred Income Fund (NYSE:HPI – Get Free Report) saw a large drop in short interest in the month...
Short Interest in iShares Global Infrastructure ETF (NASDAQ:IGF) Grows By 51.6%
iShares Global Infrastructure ETF (NASDAQ:IGF – Get Free Report) was the target of a significant increase in short interest in...
Cerence (OTCMKTS:CRNCV) Shares Up 10.1% – What’s Next?
Cerence Inc. (OTCMKTS:CRNCV – Get Free Report)’s share price traded up 10.1% during mid-day trading on Friday . The stock...
BANDAI NAMCO (OTCMKTS:NCBDY) Stock Price Down 0.1% – What’s Next?
Shares of BANDAI NAMCO Holdings Inc. (OTCMKTS:NCBDY – Get Free Report) were down 0.1% during mid-day trading on Friday ....
Diversified Energy (OTCMKTS:DECPF) Trading Up 1.3% – Here’s What Happened
Diversified Energy Company PLC (OTCMKTS:DECPF – Get Free Report)’s share price shot up 1.3% during mid-day trading on Friday ....
OFS Credit (NASDAQ:OCCI) Stock Price Up 1.8% – Time to Buy?
OFS Credit Company, Inc. (NASDAQ:OCCI – Get Free Report) shares shot up 1.8% on Friday . The stock traded as...